See more funds from M&G UK
See more funds in the Europe Including UK sector
See more funds managed by: Charlie Anniss
M&G Pan European B Acc EUR
Fund Overview |
|
|---|---|
| Unit Price |
10.14p
24/05/2012 |
| Standard Initial Charge | n/a |
| TQ Invest Discount | 0.00% |
| Initial Charge Through TQ Invest | n/a |
| Annual Management Charge | n/a |
| Total Expense Ratio | 2.17% |
| Fund size | £165,870,000 |
| Usable in ISA | No |
Fund holding information
| Holding | Weighting |
|---|---|
| Nestle Sa | 3.70% |
| Unilever | 3.20% |
| Hsbc Hldgs | 3.10% |
| Novartis Ag | 3.10% |
| Roche Hldg Ag | 2.80% |
| Zurich Financial Services | 2.60% |
| Ericsson Nikola Tesla | 2.50% |
| Glaxosmithkline | 2.40% |
| Carnival Corp | 2.30% |
| Total S.A | 2.30% |
| Sector | Weighting |
|---|---|
| Consumer Products | 27.00% |
| Basic Materials | 20.90% |
| Industrials | 15.60% |
| Telecom, Media & Technology | 11.80% |
| Financials | 11.30% |
| Health Care | 11.10% |
| Money Market | 2.40% |
| Region | Weighting |
|---|---|
| Europe Ex Uk | 62.60% |
| Uk | 23.90% |
| Equities | 11.10% |
| Money Market | 2.40% |
| Asset Type | Weighting |
|---|---|
| European Equities | 62.60% |
| Uk Equities | 23.90% |
| International Equities | 11.10% |
| Money Market | 2.40% |
Data provided by 
The value of this investment and the income from it can go down as well as up. Past performance should not be regarded as a guide to the future. The investment described may not be suitable for all recipients and this factsheet does not constitute personalised investment advice. No liability is accepted for any loss arising from errors or omissions.